Skip to main content
Clinical Trials/ACTRN12610000499088
ACTRN12610000499088Not yet recruitingPhase 3

Study of the tolerability and effectiveness for surgeons and patients of the use of dexmedetomidine for cystoscopy, hysteroscopy and transrectal ultrasound guided biopsy of the prostate (TRUS biopsy).

Michael Keane0 sites45 target enrollmentStarted: June 17, 2010Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
45

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • patients scheduled for cystoscopy, hysteroscopy and TRUS biopsy

Exclusion Criteria

  • American Society of Anesthesiologists (ASA) score of IV;
  • patients who require an epidural or spinal anesthesia;
  • acute unstable angina or acute myocardial infarction in the past 6 week;
  • heart rate less than 50;
  • systolic blood pressure less than 90 mm Hg;
  • third-degree heart block unless the patient has a pacemaker

Investigators

Sponsor
Michael Keane

Similar Trials